Daniel K. Spiegelman, Director at MYRIAD GENETICS INC (MYGN), sold 6,424 shares at $19.25 ($124K) on 2022-06-06, disclosed to the SEC on 2022-06-06.
Open-market sale of $124k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |
| BMRN | SELL | 2019-04-03 | $1.2M | — | Filing → |